ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Wisconsin » Hematology Oncology

Top Hematology Oncology Prescribers in Wisconsin

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
LAWRENCE CLOUSE MD

Hematology Oncology

718

$496K

103
90 are 65+

11%
patients receiving schedule two controlled substances

Avg: 13%

0%
patients receiving schedule three controlled substances

Avg: 7%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 15%

$691
Average prescription price

Avg: $356

DHIMANT PATEL MD

Hematology Oncology

707

$772K

98
84 are 65+

14%
patients receiving schedule two controlled substances

Avg: 13%

15%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 15%

$1093
Average prescription price

Avg: $356

XIN YAO M.D.

Hematology Oncology

700

$196K

106
95 are 65+

15%
patients receiving schedule two controlled substances

Avg: 13%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

11%
prescriptions for brand name drugs

Avg: 15%

$280
Average prescription price

Avg: $356

SAYED MEHDI HAMADANI M.D

Hematology Oncology

696

$284K

71
42 are 65+

25%
patients receiving schedule two controlled substances

Avg: 13%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 15%

$408
Average prescription price

Avg: $356

MAGDALENA FLEJSIEROWICZ MD

Hematology Oncology

679

$189K

101
62 are 65+

18%
patients receiving schedule two controlled substances

Avg: 13%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

12%
prescriptions for brand name drugs

Avg: 15%

$278
Average prescription price

Avg: $356

MARY MISISCHIA D.O.

Hematology Oncology

674

$107K

151
120 are 65+

0%
patients receiving schedule two controlled substances

Avg: 13%

19%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

12%
prescriptions for brand name drugs

Avg: 15%

$158
Average prescription price

Avg: $356

CHRISTIAN DEBRANIN MD

Hematology Oncology

671

$171K

161
134 are 65+

16%
patients receiving schedule two controlled substances

Avg: 13%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

17%
prescriptions for brand name drugs

Avg: 15%

$256
Average prescription price

Avg: $356

WILLIAM MATTHAEUS MD

Hematology Oncology

630

$342K

73
54 are 65+

15%
patients receiving schedule two controlled substances

Avg: 13%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 15%

$543
Average prescription price

Avg: $356

SANTOSH GOWDA M.D.

Hematology Oncology

618

$149K

100
78 are 65+

0%
patients receiving schedule two controlled substances

Avg: 13%

21%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

11%
prescriptions for brand name drugs

Avg: 15%

$241
Average prescription price

Avg: $356

STEPHEN STROTHER M.D.

Hematology Oncology

598

$428K

90
83 are 65+

12%
patients receiving schedule two controlled substances

Avg: 13%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 15%

$716
Average prescription price

Avg: $356

ALI BSEISO MD

Hematology Oncology

594

$633K

73
67 are 65+

0%
patients receiving schedule two controlled substances

Avg: 13%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 15%

$1065
Average prescription price

Avg: $356

RIFAT ELKHATIB MD

Hematology Oncology

582

$164K

112
91 are 65+

14%
patients receiving schedule two controlled substances

Avg: 13%

0%
patients receiving schedule three controlled substances

Avg: 7%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

9%
prescriptions for brand name drugs

Avg: 15%

$281
Average prescription price

Avg: $356

NANCY DAVIS MD

Hematology Oncology

581

$80.1K

113
87 are 65+

20%
patients receiving schedule two controlled substances

Avg: 13%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

13%
prescriptions for brand name drugs

Avg: 15%

$138
Average prescription price

Avg: $356

WILLIAM HOCKING MD

Hematology Oncology

563

$206K

84
74 are 65+

0%
patients receiving schedule two controlled substances

Avg: 13%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

13%
prescriptions for brand name drugs

Avg: 15%

$366
Average prescription price

Avg: $356

UMANG GAUTAM MD

Hematology Oncology

562

$38.5K

83
60 are 65+

22%
patients receiving schedule two controlled substances

Avg: 13%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

15%
prescriptions for brand name drugs

Avg: 15%

$69
Average prescription price

Avg: $356

AMY STELLA M.D.

Hematology Oncology

558

$81.2K

113
90 are 65+

0%
patients receiving schedule two controlled substances

Avg: 13%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

12%
prescriptions for brand name drugs

Avg: 15%

$145
Average prescription price

Avg: $356

YAMIL ARBAJE MD

Hematology Oncology

557

$242K

134
118 are 65+

13%
patients receiving schedule two controlled substances

Avg: 13%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

8%
prescriptions for brand name drugs

Avg: 15%

$435
Average prescription price

Avg: $356

COLIN MOONEY MD

Hematology Oncology

554

$187K

91
77 are 65+

16%
patients receiving schedule two controlled substances

Avg: 13%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

9%
prescriptions for brand name drugs

Avg: 15%

$337
Average prescription price

Avg: $356

ARLENE GAYLE MD

Hematology Oncology

543

$311K

86
66 are 65+

14%
patients receiving schedule two controlled substances

Avg: 13%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

17%
prescriptions for brand name drugs

Avg: 15%

$573
Average prescription price

Avg: $356

EMILY ROBINSON MD

Hematology Oncology

531

$147K

68
49 are 65+

0%
patients receiving schedule two controlled substances

Avg: 13%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

15%
prescriptions for brand name drugs

Avg: 15%

$276
Average prescription price

Avg: $356

JAMES HEUN M.D.

Hematology Oncology

526

$126K

125
111 are 65+

19%
patients receiving schedule two controlled substances

Avg: 13%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

9%
prescriptions for brand name drugs

Avg: 15%

$239
Average prescription price

Avg: $356

JOHN BURFEIND MD

Hematology Oncology

516

$357K

91
80 are 65+

0%
patients receiving schedule two controlled substances

Avg: 13%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 15%

$691
Average prescription price

Avg: $356

EHAB ATALLAH MD

Hematology Oncology

515

$934K

69
49 are 65+

0%
patients receiving schedule two controlled substances

Avg: 13%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

39%
prescriptions for brand name drugs

Avg: 15%

$1813
Average prescription price

Avg: $356

MUHAMMAD MOID MD

Hematology Oncology

512

$53.9K

124
107 are 65+

15%
patients receiving schedule two controlled substances

Avg: 13%

15%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

8%
prescriptions for brand name drugs

Avg: 15%

$105
Average prescription price

Avg: $356

STEPHEN TOOTHAKER M.D.

Hematology Oncology

484

$230K

112
91 are 65+

12%
patients receiving schedule two controlled substances

Avg: 13%

10%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

14%
prescriptions for brand name drugs

Avg: 15%

$476
Average prescription price

Avg: $356

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank